BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26808925)

  • 1. Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.
    Khasraw M; Ananda S; Michael M
    Expert Rev Anticancer Ther; 2016; 16(4):391-401. PubMed ID: 26808925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy.
    Khasraw M; Yap SY; Ananda S
    Expert Rev Anticancer Ther; 2013 Apr; 13(4):451-9. PubMed ID: 23560839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
    Cives M; Strosberg J
    Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cases in the Management of GEP-NETs: Combination Regimens.
    Braiteh F
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
    Kennedy AS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
    Wang SC; Fidelman N; Nakakura EK
    Semin Oncol; 2013 Feb; 40(1):69-74. PubMed ID: 23391114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.
    Gonzalez RS
    Surg Pathol Clin; 2020 Sep; 13(3):377-397. PubMed ID: 32773190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
    Gupta S; Engstrom PF; Cohen SJ
    Clin Colorectal Cancer; 2011 Dec; 10(4):298-309. PubMed ID: 21813338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neuroendocrine tumors: a meeting of experts from Latin America.
    Costa F; Domenichini E; Garavito G; Medrano R; Mendez G; O'Connor J; Rojas W; Torres S; Younes RN; Delle Fave G; Oberg K
    Neuroendocrinology; 2008; 88(3):235-42. PubMed ID: 18663282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies.
    Halfdanarson TR; Strosberg JR
    Curr Clin Pharmacol; 2015; 10(4):305-10. PubMed ID: 26548907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tumors: current recommendations for diagnosis and surgical management.
    Joseph S; Wang YZ; Boudreaux JP; Anthony LB; Campeau R; Raines D; O'Dorisio T; Go VL; Vinik AI; Cundiff J; Woltering EA
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):205-31, x. PubMed ID: 21349420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.
    de Mestier L; Dromain C; d'Assignies G; Scoazec JY; Lassau N; Lebtahi R; Brixi H; Mitry E; Guimbaud R; Courbon F; d'Herbomez M; Cadiot G
    Endocr Relat Cancer; 2014 Jun; 21(3):R105-20. PubMed ID: 24351682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digestive neuroendocrine tumors].
    de Mestier L; Deguelte-Lardière S; Brixi H; Kianmanesh R; Cadiot G
    Rev Med Interne; 2016 Aug; 37(8):551-60. PubMed ID: 26897113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tale of two tumors: treating pancreatic and extrapancreatic neuroendocrine tumors.
    Halperin DM; Kulke MH; Yao JC
    Annu Rev Med; 2015; 66():1-16. PubMed ID: 25341008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on medical treatment of small intestinal neuroendocrine tumors.
    Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
    Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?
    Lamarca A; Elliott E; Barriuso J; Backen A; McNamara MG; Hubner R; Valle JW
    Cancer Treat Rev; 2016 Mar; 44():26-41. PubMed ID: 26855376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature review.
    Berardi R; Rinaldi S; Torniai M; Morgese F; Partelli S; Caramanti M; Onofri A; Polenta V; Pagliaretta S; Falconi M; Cascinu S
    Crit Rev Oncol Hematol; 2016 Feb; 98():264-74. PubMed ID: 26643525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.